Sun Pharmaceuticals Industries Ltd Quarterly Results

Gross Sales

12,524.51

11,813.33

12,156.86

12,003.11

11,785.15

Excise Duty

0

0

0

0

0

Net Sales

12,524.51

11,813.33

12,156.86

12,003.11

11,785.15

Other Operating Income

128.24

169.57

223.84

189.3

155.69

Other Income

532.55

605.94

250.2

293.61

204.44

Total Income

13,185.3

12,588.84

12,630.9

12,486.02

12,145.28

Total Expenditure

9,045.13

9,049.39

8,973.68

9,013.03

8,931.94

PBIDT

4,140.17

3,539.45

3,657.22

3,472.99

3,213.34

Interest

61.54

73.57

34.73

49.29

80.88

PBDT

4,078.63

3,465.88

3,622.49

3,423.7

3,132.46

Depreciation

655.13

650.36

622.14

632.82

651.32

Minority Interest Before NP

0

0

0

0

0

Tax

552.25

148.93

432.32

390.1

468.1

Deferred Tax

0

0

0

0

0

Reported Profit After Tax

2,871.25

2,666.59

2,568.03

2,400.78

2,013.04

Minority Interest After NP

24.89

4.16

36.79

9.59

-16.89

Net Profit after Minority Interest

2,835.62

2,654.58

2,523.75

2,375.51

2,022.54

Extra-ordinary Items

0

-96.26

-59.75

0

-261.96

Adjusted Profit After Extra-ordinary item

2,835.62

2,750.84

2,583.5

2,375.51

2,284.5

EPS (Unit Curr.)

11.8

11.1

10.5

9.9

8.4

Book Value (Unit Curr.)

0

0

0

0

0

Dividend (%)

0

0

850

0

0

Equity

239.93

239.93

239.93

239.93

239.93

Public Shareholding (Number)

0

0

0

0

0

Public Shareholding (%)

0

0

0

0

0

Pledged/Encumbered - No. of Shares

0

0

0

0

0

Pledged/Encumbered - % in Total Promoters Holding

0

0

0

0

0

Pledged/Encumbered - % in Total Equity

0

0

0

0

0

Non Encumbered - No. of Shares

0

0

0

0

0

Non Encumbered - % in Total Promoters Holding

0

0

0

0

0

Non Encumbered - % in Total Equity

0

0

0

0

0

PBIDTM(%)

33.05

29.96

30.08

28.93

27.26

PBDTM(%)

32.56

29.33

29.79

28.52

26.57

PATM(%)

22.92

22.57

21.12

20

17.08